Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Jul 1;100(1):197–203. doi: 10.1172/JCI119513

Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles.

N E Tawa Jr 1, R Odessey 1, A L Goldberg 1
PMCID: PMC508180  PMID: 9202072

Abstract

Several observations have suggested that the enhanced proteolysis and atrophy of skeletal muscle in various pathological states is due primarily to activation of the ubiquitin-proteasome pathway. To test this idea, we investigated whether peptide aldehyde inhibitors of the proteasome, N-acetyl-leucyl-leucyl-norleucinal (LLN), or the more potent CBZ-leucyl-leucyl-leucinal (MG132) suppressed proteolysis in incubated rat skeletal muscles. These agents (e.g., MG132 at 10 microM) inhibited nonlysosomal protein breakdown by up to 50% (P < 0.01), and this effect was rapidly reversed upon removal of the inhibitor. The peptide aldehydes did not alter protein synthesis or amino acid pools, but improved overall protein balance in the muscle. Upon treatment with MG132, ubiquitin-conjugated proteins accumulated in the muscle. The inhibition of muscle proteolysis correlated with efficacy against the proteasome, although these agents could also inhibit calpain-dependent proteolysis induced with Ca2+. These inhibitors had much larger effects on proteolysis in atrophying muscles than in controls. In the denervated soleus undergoing atrophy, the increase in ATP-dependent proteolysis was reduced 70% by MG132 (P < 0.001). Similarly, the rise in muscle proteolysis induced by administering thyroid hormones was reduced 40-70% by the inhibitors. Finally, in rats made septic by cecal puncture, the increase in muscle proteolysis was completely blocked by MG132. Thus, the enhanced proteolysis in many catabolic states (including denervation, hyperthyroidism, and sepsis) is due to a proteasome-dependent pathway, and inhibition of proteasome function may be a useful approach to reduce muscle wasting.

Full Text

The Full Text of this article is available as a PDF (172.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey J. L., Wang X., England B. K., Price S. R., Ding X., Mitch W. E. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest. 1996 Mar 15;97(6):1447–1453. doi: 10.1172/JCI118566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baracos V. E., DeVivo C., Hoyle D. H., Goldberg A. L. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol. 1995 May;268(5 Pt 1):E996–1006. doi: 10.1152/ajpendo.1995.268.5.E996. [DOI] [PubMed] [Google Scholar]
  3. Baracos V., Greenberg R. E., Goldberg A. L. Influence of calcium and other divalent cations on protein turnover in rat skeletal muscle. Am J Physiol. 1986 Jun;250(6 Pt 1):E702–E710. doi: 10.1152/ajpendo.1986.250.6.E702. [DOI] [PubMed] [Google Scholar]
  4. Coux O., Tanaka K., Goldberg A. L. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem. 1996;65:801–847. doi: 10.1146/annurev.bi.65.070196.004101. [DOI] [PubMed] [Google Scholar]
  5. Furuno K., Goldberg A. L. The activation of protein degradation in muscle by Ca2+ or muscle injury does not involve a lysosomal mechanism. Biochem J. 1986 Aug 1;237(3):859–864. doi: 10.1042/bj2370859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Furuno K., Goodman M. N., Goldberg A. L. Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. J Biol Chem. 1990 May 25;265(15):8550–8557. [PubMed] [Google Scholar]
  7. Goldberg A. L., Stein R., Adams J. New insights into proteasome function: from archaebacteria to drug development. Chem Biol. 1995 Aug;2(8):503–508. doi: 10.1016/1074-5521(95)90182-5. [DOI] [PubMed] [Google Scholar]
  8. Goldberg A. L., Tischler M., DeMartino G., Griffin G. Hormonal regulation of protein degradation and synthesis in skeletal muscle. Fed Proc. 1980 Jan;39(1):31–36. [PubMed] [Google Scholar]
  9. Gronostajski R. M., Goldberg A. L., Pardee A. B. The role of increased proteolysis in the atrophy and arrest of proliferation in serum-deprived fibroblasts. J Cell Physiol. 1984 Oct;121(1):189–198. doi: 10.1002/jcp.1041210124. [DOI] [PubMed] [Google Scholar]
  10. Hershey J. W. Translational control in mammalian cells. Annu Rev Biochem. 1991;60:717–755. doi: 10.1146/annurev.bi.60.070191.003441. [DOI] [PubMed] [Google Scholar]
  11. Hershko A., Ciechanover A. The ubiquitin system for protein degradation. Annu Rev Biochem. 1992;61:761–807. doi: 10.1146/annurev.bi.61.070192.003553. [DOI] [PubMed] [Google Scholar]
  12. Jensen T. J., Loo M. A., Pind S., Williams D. B., Goldberg A. L., Riordan J. R. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell. 1995 Oct 6;83(1):129–135. doi: 10.1016/0092-8674(95)90241-4. [DOI] [PubMed] [Google Scholar]
  13. Kettelhut I. C., Wing S. S., Goldberg A. L. Endocrine regulation of protein breakdown in skeletal muscle. Diabetes Metab Rev. 1988 Dec;4(8):751–772. doi: 10.1002/dmr.5610040805. [DOI] [PubMed] [Google Scholar]
  14. Lee D. H., Goldberg A. L. Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J Biol Chem. 1996 Nov 1;271(44):27280–27284. doi: 10.1074/jbc.271.44.27280. [DOI] [PubMed] [Google Scholar]
  15. Löwe J., Stock D., Jap B., Zwickl P., Baumeister W., Huber R. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science. 1995 Apr 28;268(5210):533–539. doi: 10.1126/science.7725097. [DOI] [PubMed] [Google Scholar]
  16. Medina R., Wing S. S., Goldberg A. L. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J. 1995 May 1;307(Pt 3):631–637. doi: 10.1042/bj3070631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Medina R., Wing S. S., Haas A., Goldberg A. L. Activation of the ubiquitin-ATP-dependent proteolytic system in skeletal muscle during fasting and denervation atrophy. Biomed Biochim Acta. 1991;50(4-6):347–356. [PubMed] [Google Scholar]
  18. Mitch W. E., Goldberg A. L. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med. 1996 Dec 19;335(25):1897–1905. doi: 10.1056/NEJM199612193352507. [DOI] [PubMed] [Google Scholar]
  19. Mitch W. E., Medina R., Grieber S., May R. C., England B. K., Price S. R., Bailey J. L., Goldberg A. L. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest. 1994 May;93(5):2127–2133. doi: 10.1172/JCI117208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Price S. R., Bailey J. L., Wang X., Jurkovitz C., England B. K., Ding X., Phillips L. S., Mitch W. E. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest. 1996 Oct 15;98(8):1703–1708. doi: 10.1172/JCI118968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rock K. L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., Goldberg A. L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 1994 Sep 9;78(5):761–771. doi: 10.1016/s0092-8674(94)90462-6. [DOI] [PubMed] [Google Scholar]
  22. Sherwood S. W., Kung A. L., Roitelman J., Simoni R. D., Schimke R. T. In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the neutral cysteine protease inhibitor N-acetylleucylleucylnorleucinal. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3353–3357. doi: 10.1073/pnas.90.8.3353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Solomon V., Goldberg A. L. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem. 1996 Oct 25;271(43):26690–26697. doi: 10.1074/jbc.271.43.26690. [DOI] [PubMed] [Google Scholar]
  24. Tawa N. E., Jr, Goldberg A. L. Suppression of muscle protein turnover and amino acid degradation by dietary protein deficiency. Am J Physiol. 1992 Aug;263(2 Pt 1):E317–E325. doi: 10.1152/ajpendo.1992.263.2.E317. [DOI] [PubMed] [Google Scholar]
  25. Tawa N. E., Jr, Kettelhut I. C., Goldberg A. L. Dietary protein deficiency reduces lysosomal and nonlysosomal ATP-dependent proteolysis in muscle. Am J Physiol. 1992 Aug;263(2 Pt 1):E326–E334. doi: 10.1152/ajpendo.1992.263.2.E326. [DOI] [PubMed] [Google Scholar]
  26. Tiao G., Fagan J. M., Samuels N., James J. H., Hudson K., Lieberman M., Fischer J. E., Hasselgren P. O. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J Clin Invest. 1994 Dec;94(6):2255–2264. doi: 10.1172/JCI117588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Voisin L., Breuillé D., Combaret L., Pouyet C., Taillandier D., Aurousseau E., Obled C., Attaix D. Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways. J Clin Invest. 1996 Apr 1;97(7):1610–1617. doi: 10.1172/JCI118586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wing S. S., Goldberg A. L. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol. 1993 Apr;264(4 Pt 1):E668–E676. doi: 10.1152/ajpendo.1993.264.4.E668. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES